Literature DB >> 19176466

Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms.

Gunnar Kleinau1, Gerd Krause.   

Abstract

The TSH receptor (TSHR) together with the homologous lutropin/choriogonadotropin receptor and the follitropin receptor are glycoprotein hormone receptors (GPHRs). They constitute a subfamily of the rhodopsin-like G protein-coupled receptors with seven transmembrane helices. GPHRs and their corresponding hormones are pivotal proteins with respect to a variety of physiological functions. The identification and characterization of intra- and intermolecular signaling determinants as well as signaling mechanisms are prerequisites to gaining molecular insights into functions and (pathogenic) dysfunctions of GPHRs. Knowledge about activation mechanisms is fragmentary, and the specific aspects have still not been understood in their entirety. Therefore, here we critically review the data available for these receptors and bring together structural and functional findings with a focus on the important large extracellular portion of the TSHR. One main focus is the particular function of structural determinants in the initial steps of the activation such as: 1) hormone binding at the extracellular site; 2) hormone interaction at a second binding site in the hinge region; 3) signal regulation via sequence motifs in the hinge region; and 4) synergistic signal amplification by cooperative effects of the extracellular loops toward the transmembrane region. Comparison and consolidation of data from the homologous glycoprotein hormone receptors TSHR, follitropin receptor, and lutropin/choriogonadotropin receptor provide an overview of extracellular mechanisms of signal initiation, conduction, and regulation at the TSHR and homologous receptors. Finally, we address the issue of structural implications and suggest a refined scenario for the initial signaling process on GPHRs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176466     DOI: 10.1210/er.2008-0044

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  43 in total

1.  The Synthesis and Evaluation of Dihydroquinazolin-4-ones and Quinazolin-4-ones as Thyroid Stimulating Hormone Receptor Agonists.

Authors:  Erika E Englund; Susanne Neumann; Elena Eliseeva; Joshua G McCoy; Steven Titus; Wei Zheng; Noel Southall; Paul Shin; William Leister; Craig J Thomas; James Inglese; Christopher P Austin; Marvin C Gershengorn; Wenwei Huang
Journal:  Medchemcomm       Date:  2011-10       Impact factor: 3.597

2.  The rs1991517 polymorphism is a genetic risk factor for congenital hypothyroidism.

Authors:  Yedukondalu Kollati; Radha Rama Devi Akella; Shaik Mohammad Naushad; Maunika Thalla; G Bhanuprakash Reddy; Vijaya R Dirisala
Journal:  3 Biotech       Date:  2020-06-01       Impact factor: 2.406

3.  Evidence for activity-regulated hormone-binding cooperativity across glycoprotein hormone receptor homomers.

Authors:  Maxime Zoenen; Eneko Urizar; Stéphane Swillens; Gilbert Vassart; Sabine Costagliola
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

4.  TSH receptor extracellular region mutations in thyroid functioning nodules: further evidence for the functional role of this region in the receptor activation.

Authors:  D Russo; G Costante; R Bruno; M Sponziello; G Tamburrano; M Dima; R Sacco; L Giacomelli; C Durante; S Filetti
Journal:  Endocrine       Date:  2011-08-24       Impact factor: 3.633

5.  Targeting TSH and IGF-1 Receptors to Treat Thyroid Eye Disease.

Authors:  Susanne Neumann; Christine C Krieger; Marvin C Gershengorn
Journal:  Eur Thyroid J       Date:  2020-11-02

6.  Expression of BANCR promotes papillary thyroid cancer by targeting thyroid stimulating hormone receptor.

Authors:  Haitao Zheng; Jie Xu; Shaolong Hao; Xincheng Liu; Jinrao Ning; Xicheng Song; Lixin Jiang; Zongying Liu
Journal:  Oncol Lett       Date:  2018-05-25       Impact factor: 2.967

7.  Disrupted TSH Receptor Expression in Female Mouse Lung Fibroblasts Alters Subcellular IGF-1 Receptor Distribution.

Authors:  Stephen J Atkins; Stephen I Lentz; Roshini Fernando; Terry J Smith
Journal:  Endocrinology       Date:  2015-09-21       Impact factor: 4.736

Review 8.  Lessons from mouse models of thyroid cancer.

Authors:  Caroline S Kim; Xuguang Zhu
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

9.  Thyrostimulin, but not thyroid-stimulating hormone (TSH), acts as a paracrine regulator to activate the TSH receptor in mammalian ovary.

Authors:  Su-Chin Sun; Pei-Jen Hsu; Fang-Ju Wu; Sheng-Hsiang Li; Chung-Hao Lu; Ching-Wei Luo
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

10.  An unbalanced translocation unmasks a recessive mutation in the follicle-stimulating hormone receptor (FSHR) gene and causes FSH resistance.

Authors:  Amla Kuechler; Berthold P Hauffa; Angela Köninger; Gunnar Kleinau; Beate Albrecht; Bernhard Horsthemke; Jörg Gromoll
Journal:  Eur J Hum Genet       Date:  2010-01-20       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.